Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this newsletter: Andy Dao, PharmD Candidate, University of South Florida Taneja College of Pharmacy Kornelia Ilias, Creighton University | School of Pharmacy and Health Professions Doctor of Pharmacy Candidate Class of 2022 Emmanuella Louissaint, PharmD candidate, LECOM College of Pharmacy Trina Maglalang RPh, 2022 PharmD Candidate, University of Colorado Ding Nguyen, PharmD Candidate, University of South Florida Taneja College of Pharmacy | 
We keep seeing more evidence on the value of GLP-1 agonists and SGLT-2 inhibitors on protection and improvement in cardio and renal outcomes. This week when Steve and I looked at features from our interns to publish, we selected multiple articles that show how these classes of drugs are making a difference both for diabetes and the comorbidities associated with diabetes.